Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Infect Dis Now ; 51(3): 253-259, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33166612

RESUMEN

BACKGROUND: We compared the relapse rate at 1 year in patients with vertebral osteomyelitis with or without associated endocarditis. PATIENTS AND METHODS: We conducted a retrospective cohort study. Inclusion criteria were patients hospitalized in the infectious disease, rheumatology, cardiology, cardiovascular surgery and two internal medicine units for vertebral osteomyelitis (blood culture and/or disco-vertebral biopsy) and compatible imaging, between 2014 and 2017. We compared patients with associated endocarditis (VO-EI group) and without endocarditis (VO group) using logistic regression to determine the factors associated with relapse and EI. The main outcome was the relapse rate at 1 year. RESULTS: Out of the 207 eligible patients, 62 were included (35 in the VO group and 27 in the VO-EI group). Four patients presented with a new VO during follow-up, one (2.86%) patient in VO group and three (11.11%) in VO-EI group (P=0.68). There were more men in the VO-EI group than in the VO group (74.07% vs. 48.57%, P=0.04), valvulopathies (13/27 vs. 8/35, P=0.06), vertebral localization (1.22±0.50 vs. 1.03±0.17, P=0.04) and septic kidney embolism (5/27 vs. 0/35, P=0.01). Control blood cultures were more often positive in the VO-EI group (12/27 vs. 8/35, P=0.04). In 45% of patients, the germ was a staphylococcus, 29% streptococci, 10% enterococci, 10% gram-negative bacillus (GNB). There were more streptococci and enterococci in the VO-EI group than in the VO group (44.44% vs. 17.14% and 18.52% vs. 8.57%, respectively). Antibiotic safety was good and comparable between groups. CONCLUSION: In a relatively small population, we did not find significantly more relapse in the endocarditis group.


Asunto(s)
Antibacterianos/administración & dosificación , Discitis/tratamiento farmacológico , Endocarditis Bacteriana/tratamiento farmacológico , Osteomielitis/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Discitis/complicaciones , Endocarditis/complicaciones , Endocarditis/tratamiento farmacológico , Endocarditis Bacteriana/complicaciones , Enterococcus/aislamiento & purificación , Femenino , Bacterias Gramnegativas/aislamiento & purificación , Humanos , Masculino , Persona de Mediana Edad , Osteomielitis/complicaciones , Recurrencia , Estudios Retrospectivos , Columna Vertebral/microbiología , Staphylococcus/aislamiento & purificación , Streptococcus/aislamiento & purificación , Resultado del Tratamiento
2.
Chemosphere ; 36(3): 419-26, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9451808

RESUMEN

Polychlorinated dibenzodioxins (PCDDs), Polychlorinated dibenzofurans (PCDFs) and Polychlorinated biphenyls (PCBs) are among the most toxic environmental pollutants. We determined blood levels of these compounds in a population sample of the city of Mataró, Spain. Blood samples were drawn from a randomly selected sample of 198 subjects, of both genders, aged 18 to 69 years. These samples were pooled into 10 groups for laboratory analysis. For males, total level of PCDDs was 505.7 ppt, of PCDFs was 26.7 ppt, and the international toxic equivalent (I-TEQ) was 12.5. For females the levels were 739 ppt, 28.8 ppt and 14.71-TEQ, respectively. The most important contributors to the total I-TEQ were HexaCDD, PentaCDD and PentaCDF. The blood concentration of total PCBs was 2.02 mg/l in males, and 1.58 mg/l in females. Levels of PCDDs, PCDFs and PCBs increased by age in both sexes. The levels of PCDDs and PCDFs in residents of this Mediterranean city are among the lowest observed in industrialized countries.


Asunto(s)
Benzofuranos/sangre , Exposición a Riesgos Ambientales , Bifenilos Policlorados/sangre , Dibenzodioxinas Policloradas/análogos & derivados , Contaminantes del Suelo/sangre , Adolescente , Adulto , Anciano , Benzofuranos/análisis , Femenino , Humanos , Incineración , Masculino , Persona de Mediana Edad , Bifenilos Policlorados/análisis , Dibenzodioxinas Policloradas/análisis , Dibenzodioxinas Policloradas/sangre , Contaminantes del Suelo/análisis , España
3.
Arch Environ Health ; 55(4): 259-67, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11005431

RESUMEN

The authors conducted a biomonitoring study in the town of Mataró, Spain, of 104 subjects who lived near (i.e., within 0.5-1.5 km) an incinerator, 97 subjects who lived far (i.e., within 3.5 km-4.0 km) from an incinerator, and 17 workers at a new municipal solid-waste incinerator. The study commenced before the incinerator started functioning in 1995, and 2 y later (1977) the authors undertook the final part of the study. Dioxins, furans, and polychlorinated biphenyls were studied in pooled blood samples (n = 22), and individual blood and urine samples were analyzed for the detection of lead, chromium, cadmium, and mercury. In 1995, dioxin blood levels were low-both among those living close to the incinerator (mean = 13.5 ng international-dioxin toxic equivalents/kg fat) and among those living far away (mean = 13.4 ng international-dioxin toxic equivalents/kg fat). In 1997, dioxin and polychlorinated biphenyl levels had increased in both groups of residents by approximately 25% and 12%, respectively. (The increase in dioxin levels was about 10% when the authors took into account the mean of two repeated quality-control analyses.) Blood lead levels decreased, but no difference was observed for chromium, cadmium, and mercury. Minimal changes were seen among workers. Given the low dioxin stack emissions from this plant (mean = 2.5-0.98 ng international-dioxin toxic equivalents/m3) and that the blood dioxin levels did not depend on distance of residence from the incinerator, it would appear unlikely that the small increase in dioxin blood levels resulted from the incinerator's emissions.


Asunto(s)
Contaminantes Atmosféricos/análisis , Monitoreo del Ambiente/métodos , Incineración , Exposición Profesional/análisis , Eliminación de Residuos/métodos , Adolescente , Adulto , Anciano , Contaminantes Atmosféricos/efectos adversos , Análisis Químico de la Sangre , Dioxinas/sangre , Monitoreo del Ambiente/estadística & datos numéricos , Femenino , Humanos , Gobierno Local , Masculino , Metales Pesados/sangre , Metales Pesados/orina , Persona de Mediana Edad , Exposición Profesional/efectos adversos , Bifenilos Policlorados/sangre , España , Urinálisis
4.
Chirurgia (Bucur) ; 95(3): 273-7, 2000.
Artículo en Ro | MEDLINE | ID: mdl-14768333

RESUMEN

The authors present the experience of the surgery section in patients treatment with oesophagian or gastric lesions after caustic substances ingestion. From a group of 70 patients who were treated in a conservative way (with medicines and dilatations) 60 of them returned to the surgery for nourishment gastrostomy. In two cases, the oesophagian and gastric lesions was established preoperations trough radiologic examination and in thirteen cases the lesions were found intraoperation. The adopted attitude is exemplified presenting a case. Under a general anaesthesia is done a limited resection (about 3 cm) with termino-terminal anastomosis of the stenosed antral area keeping the vascular arches of the little and big gastric curvature. A minimal a la Gavriliu gastrostomy is mounted on the vertical area of the little curvature. Through the gastrostomy (Petzzer) probe is put a tube of perfusor to the first jejununal ansa. In the first 48 hours the Petzeer is used for the gastric drainage in the perfusor probe for feeding. After 48 hours the jejununal probe is taken away and the gastrostomic feeding begins. After six mouths from the caustic ingestion 25 patients come back again for oesophagian reconstruction. For 24 patients the Gavriliu I, II proceeding is applied and for a case it is used the small intestine ansa. They lost 3 patients (2 with gastric tube and 1 with intestinal ansa). The evolution in 24 years time was very good.


Asunto(s)
Quemaduras Químicas/cirugía , Esofagoplastia/métodos , Esófago/lesiones , Gastrostomía/métodos , Estómago/lesiones , Adulto , Anciano , Quemaduras Químicas/etiología , Quemaduras Químicas/mortalidad , Cáusticos/efectos adversos , Estenosis Esofágica/inducido químicamente , Estenosis Esofágica/cirugía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Estómago/cirugía , Gastropatías/inducido químicamente , Gastropatías/cirugía , Tasa de Supervivencia
5.
Obes Rev ; 13(4): 368-80, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22133030

RESUMEN

Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients and has been identified as a factor of poor prognosis. Causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied. Here is reviewed the current knowledge about the main causes and mechanisms involved in body weight change. Special emphasis is placed on factors associated with weight variation which could potentially be involved in the risk of relapse in breast cancer survivors. In recent decades, some studies have investigated the causes of weight variation by studying energy balance of breast cancer patients during chemotherapy. Weight gain or loss may be the consequence of energy imbalance through different factors linked with chemotherapy, such as poor treatment tolerance, decreased muscle mass and function, or hormonal alterations. This results in body composition modifications in favour of fat gain and/or lean body mass loss. Increased adipose tissue, especially in the abdominal region, could induce metabolic disturbances such as insulin resistance, through various pathways involving adipokines. These molecules have growth properties and could therefore play a role in cancer relapse. Understanding such mechanisms is key to developing preventive strategies for improving the prognosis of early-stage breast cancer patients.


Asunto(s)
Adipoquinas/metabolismo , Antineoplásicos/efectos adversos , Composición Corporal , Neoplasias de la Mama/metabolismo , Metabolismo Energético/efectos de los fármacos , Tejido Adiposo/metabolismo , Tejido Adiposo/patología , Antineoplásicos/uso terapéutico , Composición Corporal/efectos de los fármacos , Composición Corporal/fisiología , Peso Corporal/fisiología , Neoplasias de la Mama/tratamiento farmacológico , Metabolismo Energético/fisiología , Femenino , Humanos , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Pronóstico
6.
Occup Med (Lond) ; 46(5): 372-4, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8918154

RESUMEN

Acute exposure to high concentrations of cadmium fumes may cause acute chemical pneumonitis with a possibly fatal outcome. The etiologic diagnosis of acute cadmium intoxication from inhaled fumes may be difficult and can be confused with other forms of acute respiratory failure. We report on a case of a fit 53 year-old man who was exposed to cadmium fumes after flame-cutting an alloy containing around 10% of cadmium for a period of 60-75 minutes. He developed severe chemical pneumonitis and died 19 days after exposure.


Asunto(s)
Cadmio/efectos adversos , Enfermedades Pulmonares Intersticiales/inducido químicamente , Exposición Profesional/efectos adversos , Diagnóstico Diferencial , Resultado Fatal , Humanos , Enfermedades Pulmonares Intersticiales/diagnóstico , Masculino , Persona de Mediana Edad , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/fisiopatología
9.
Bull. W.H.O. (Print) ; 78(4): 565-566, 2000.
Artículo en Inglés | WHOLIS | ID: who-268114

Asunto(s)
Carta
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda